palladium has been researched along with Macular Degeneration in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berson, AM; Finger, PT; Gelman, YP; Szechter, A | 1 |
Balkin, RA; Berson, A; Bosworth, JL; Finger, PT; Riley, R; Sherr, D | 1 |
Berson, A; Finger, PT; Ng, T; Szechter, A | 1 |
Finger, PT | 1 |
1 review(s) available for palladium and Macular Degeneration
Article | Year |
---|---|
Implant radiotherapy for exudative macular degeneration associated with subretinal neovascularization.
Topics: Brachytherapy; Drug Implants; Humans; Macular Degeneration; Palladium; Radioisotopes; Retinal Neovascularization; Strontium Radioisotopes | 2001 |
3 trial(s) available for palladium and Macular Degeneration
Article | Year |
---|---|
Palladium-103 plaque radiation therapy for macular degeneration: results of a 7 year study.
Topics: Brachytherapy; Follow-Up Studies; Humans; Macula Lutea; Macular Degeneration; Palladium; Radiation Dosage; Radioisotopes; Visual Acuity | 2003 |
Radiation therapy for subretinal neovascularization.
Topics: Aged; Aged, 80 and over; Brachytherapy; Female; Fluorescein Angiography; Fundus Oculi; Humans; Macular Degeneration; Male; Palladium; Radioisotopes; Radiotherapy Dosage; Radiotherapy, High-Energy; Retinal Neovascularization; Retinal Vessels; Thermoluminescent Dosimetry; Visual Acuity | 1996 |
Ophthalmic plaque radiotherapy for age-related macular degeneration associated with subretinal neovascularization.
Topics: Aged; Aged, 80 and over; Brachytherapy; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Macular Degeneration; Male; Middle Aged; Palladium; Prospective Studies; Radioisotopes; Radiotherapy Dosage; Retinal Neovascularization; Treatment Outcome; Visual Acuity | 1999 |